Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Liver Resection Versus Other Treatments for Neuroendocrine Tumours in Patients With Resectable Liver Metastases." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433317/all/Liver_resection_versus_other_treatments_for_neuroendocrine_tumours_in_patients_with_resectable_liver_metastases.
Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433317/all/Liver_resection_versus_other_treatments_for_neuroendocrine_tumours_in_patients_with_resectable_liver_metastases. Accessed February 13, 2025.
Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433317/all/Liver_resection_versus_other_treatments_for_neuroendocrine_tumours_in_patients_with_resectable_liver_metastases
Liver Resection Versus Other Treatments for Neuroendocrine Tumours in Patients With Resectable Liver Metastases [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433317/all/Liver_resection_versus_other_treatments_for_neuroendocrine_tumours_in_patients_with_resectable_liver_metastases.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases
ID - 433317
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433317/all/Liver_resection_versus_other_treatments_for_neuroendocrine_tumours_in_patients_with_resectable_liver_metastases
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -